Geneos Wealth Management’s RE/MAX Holdings RMAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-55
Closed -$2K 3064
2021
Q1
$2K Buy
+55
New +$2.16K ﹤0.01% 2922
2020
Q2
Sell
-100
Closed -$2K 2608
2020
Q1
$2K Buy
+100
New +$3.26K ﹤0.01% 2286
2019
Q4
Sell
-200
Closed -$6K 2577
2019
Q3
$6K Buy
+200
New +$5.67K ﹤0.01% 2071
2019
Q2
Sell
-31
Closed -$1K 2519
2019
Q1
$1K Buy
+31
New +$1.19K ﹤0.01% 2346
2018
Q4
Sell
-31
Closed -$1K 2467
2018
Q3
$1K Hold
31
﹤0.01% 2369
2018
Q2
$1K Hold
31
﹤0.01% 2218
2018
Q1
$1K Hold
31
﹤0.01% 2125
2017
Q4
$1K Hold
31
﹤0.01% 2123
2017
Q3
$1K Buy
31
+1
+3% +$60 ﹤0.01% 2071
2017
Q2
$1K Hold
30
﹤0.01% 2021
2017
Q1
$1K Hold
30
﹤0.01% 2011
2016
Q4
$1K Hold
30
﹤0.01% 1986
2016
Q3
$1K Hold
30
﹤0.01% 1914
2016
Q2
$1K Hold
30
﹤0.01% 1762
2016
Q1
$1K Buy
+30
New +$1.01K ﹤0.01% 1745

Other funds holding RMAX

Geneos Wealth Management's RMAX Position: Q2 2021 in Review

Geneos Wealth Management sold out of RE/MAX Holdings (RMAX) in Q2 2021, closing a stake of 55 shares — an estimated $2K sold.

Geneos Wealth Management first reported a position in RMAX in Q1 2016 and held it in 15 quarters. The position peaked at $6K in Q3 2019. 141 funds tracked by Wall St. Rank hold RMAX as of Q2 2021.

  • Geneos Wealth Management reported no remaining RE/MAX Holdings position as of Q2 2021 after selling out during the quarter.
  • Geneos Wealth Management sold 55 RE/MAX Holdings shares in Q2 2021, an estimated $2K.
  • Geneos Wealth Management first reported a position in RE/MAX Holdings in Q1 2016 and held it in 15 quarters.
  • Geneos Wealth Management's RE/MAX Holdings position peaked at $6K in Q3 2019.
  • 141 funds tracked by Wall St. Rank held RE/MAX Holdings as of Q2 2021.

Based on Geneos Wealth Management's 13F filing for Q2 2021, filed 8 Jul 2021.